Non-Hodgkin lymphoma
- 1 July 2003
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 362 (9378) , 139-146
- https://doi.org/10.1016/s0140-6736(03)13868-8
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Randomized Study to Evaluate the Use of High-Dose Therapy as Part of Primary Treatment for “Aggressive” LymphomaJournal of Clinical Oncology, 2002
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Extranodal lymphomasAnnals of Oncology, 2000
- A breakpoint map of recurrent chromosomal rearrangements in human neoplasiaNature Genetics, 1997
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy & Radiopharmaceuticals, 1997
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- Microsatellite instability in inherited and sporadic neoplasmsCurrent Opinion in Oncology, 1995
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993